Healthcare -
Biotechnology - NASDAQ - US
$ 8.67
9.61 %
$ 738 M
Market Cap
-15.76
P/E
AVXL - RESEARCH & DEVELOPMENT
Research & Development AVXL - Anavex Life Sciences Corp.
41.8 M
LAST VALUE
5.05%
2 YEAR CAGR
13.45%
5 YEAR CAGR
49.86%
10 YEAR CAGR